Sort
50,496 grants matching “lung cancer”
Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
$1,875,968Sanku Mallik · North Dakota State University · P20 · FY2017 · GM
Immunohistochemical and genomic analysis of tumors
$1,875,642Markku Miettinen · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Molecular Profiling of Clinical Specimens
$1,874,339Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
MOCSLID-DCC
$1,873,936Robert M Elashoff · University Of California Los Angeles · R01 · FY2011 · HL
SUPPLEMENTAL WORK-SARS-COV-2
$1,872,652Michael Kaytor · Humanetics Corporation · N01 · FY2021 · AI
Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology
$1,871,973Dennis E. Discher · University Of Pennsylvania · U54 · FY2019 · CA
DCTD In Vivo Preclinical Testing
$1,871,468David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2018 · CA
New Surgical Approaches For The Management Of Malignant Melanoma
$1,871,173Donald L Morton · Saint John'S Cancer Institute · P01 · FY2012 · CA
Molecular Profiling of Clinical Specimens
$1,870,854Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Brain Tumor Clinical and Clinical Research Program
$1,870,543Mark Gilbert · Division Of Basic Sciences - Nci · ZID · FY2020 · CA
Expanding the National Health Accounts
$1,868,177David M Cutler · National Bureau Of Economic Research · P01 · FY2011 · AG
microRNA-based and novel molecular therapeutics in thoracic cancers
$1,867,997Chuong Hoang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Barrett's Esophagus: Predictors of Progression
$1,866,717William M Grady · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
Inflammation Pathways and COPD in the Development of Lung Cancer
$1,866,387Ann G Schwartz · Wayne State University · R01 · FY2014 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$1,865,407Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Immunotherapy for Malignant Mesothelioma and Lung Cancer
$1,865,336Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Center for Immunotherapeutic Transport Oncophysics
$1,865,321Haifa Shen · Methodist Hospital Research Institute · U54 · FY2018 · CA
Emory University Lung Cancer SPORE
$1,865,070Suresh S Ramalingam · Emory University · P50 · FY2020 · CA
Pro-inflammatory cytokine lowering anti-inflammatory drugs
$1,864,880Nigel H. Greig · National Institute On Aging · ZIA · FY2021 · AG
Fred Hutchinson Cancer Research Center Lung SPORE
$1,863,485A. McGarry Houghton · Fred Hutchinson Cancer Research Center · P50 · FY2021 · CA
IGF::OT::IGF CORE INFRASTRUCUTE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) STUDY PERIOD OF PERFORMANCE 05/01/2015-04/30/2016
$1,861,162Carol Sweeney · University Of Utah · N01 · FY2015 · CA
MOCSLID-DCC
$1,860,592Robert M Elashoff · University Of California Los Angeles · R01 · FY2010 · HL
Studies of Occupational Cancer
$1,860,441Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Genetic Variation in Cancer Risk and Outcomes in African Americans
$1,860,121Ann G Schwartz · Wayne State University · P01 · FY2025 · CA
Development of Novel Therapeutic Strategies for Thoracic Malignancies by Targeti
$1,859,977Dao M Nguyen · Basic Sciences · Z01 · FY2007 · CA